for Journals by Title or ISSN
for Articles by Keywords
help
  Subjects -> RECREATION, TRAVEL AND TOURISM (Total: 118 journals)
    - HOTELS AND RESTAURANTS (1 journals)
    - LEISURE AND RECREATION (20 journals)
    - RECREATION, TRAVEL AND TOURISM (97 journals)

RECREATION, TRAVEL AND TOURISM (97 journals)

40 [degrees] South     Full-text available via subscription   (Followers: 2)
African Journal for Physical, Health Education, Recreation and Dance     Full-text available via subscription   (Followers: 5)
Almatourism - Journal of Tourism, Culture and Territorial Development     Open Access   (Followers: 9)
American Journal of Tourism Management     Open Access   (Followers: 3)
American Journal of Tourism Research     Open Access   (Followers: 10)
Anatolia : An International Journal of Tourism and Hospitality Research     Hybrid Journal   (Followers: 4)
Annals of Tourism Research     Hybrid Journal   (Followers: 23)
Asia Pacific Journal of Tourism Research     Hybrid Journal   (Followers: 15)
Australian Antarctic Magazine     Free   (Followers: 3)
Caderno Virtual de Turismo     Open Access  
Cornell Hospitality Quarterly     Hybrid Journal   (Followers: 5)
Craft Research     Hybrid Journal  
Cuadernos de Turismo     Open Access  
Current Issues in Tourism     Hybrid Journal   (Followers: 13)
Czech Journal of Tourism     Open Access   (Followers: 2)
EchoGéo     Open Access   (Followers: 1)
Educación física y deporte     Open Access  
El Periplo Sustentable     Open Access  
Enlightening Tourism. A Pathmaking Journal     Open Access   (Followers: 1)
Estudios y Perspectivas en Turismo     Open Access  
Event Management     Full-text available via subscription   (Followers: 5)
Gestion Turistica     Open Access  
Globe, The     Full-text available via subscription   (Followers: 3)
Hospitality & Society     Hybrid Journal   (Followers: 1)
Hospitality Review     Full-text available via subscription   (Followers: 1)
Information Technology & Tourism     Full-text available via subscription   (Followers: 16)
Interaction     Full-text available via subscription   (Followers: 2)
International Journal of Contemporary Hospitality Management     Hybrid Journal   (Followers: 8)
International Journal of Culture Tourism and Hospitality Research     Hybrid Journal   (Followers: 13)
International Journal of Digital Culture and Electronic Tourism     Hybrid Journal   (Followers: 7)
International Journal of Event and Festival Management     Hybrid Journal   (Followers: 9)
International Journal of Hospitality & Tourism Administration     Hybrid Journal   (Followers: 6)
International Journal of Hospitality Management     Hybrid Journal   (Followers: 11)
International Journal of Tourism Anthropology     Hybrid Journal   (Followers: 5)
International Journal of Tourism Policy     Hybrid Journal   (Followers: 5)
International Journal of Tourism Research     Hybrid Journal   (Followers: 12)
Journal of Applied Economics and Business     Open Access   (Followers: 1)
Journal of Business & Hotel Management     Partially Free  
Journal of China Tourism Research     Hybrid Journal   (Followers: 5)
Journal of Ecotourism     Hybrid Journal   (Followers: 3)
Journal of Environmental Management and Tourism     Open Access   (Followers: 2)
Journal of Heritage Tourism     Hybrid Journal   (Followers: 7)
Journal of Hospitality & Tourism Education     Hybrid Journal   (Followers: 1)
Journal of Hospitality & Tourism Research     Hybrid Journal   (Followers: 10)
Journal of Hospitality and Tourism Management     Full-text available via subscription   (Followers: 9)
Journal of Hospitality and Tourism Technology     Hybrid Journal   (Followers: 1)
Journal of Hospitality Financial Management     Open Access   (Followers: 3)
Journal of Hospitality Marketing & Management     Hybrid Journal   (Followers: 8)
Journal of Park and Recreation Administration     Full-text available via subscription   (Followers: 2)
Journal of Place Management and Development     Hybrid Journal   (Followers: 2)
Journal of Policy Research in Tourism, Leisure and Events     Hybrid Journal   (Followers: 8)
Journal of Quality Assurance in Hospitality & Tourism     Hybrid Journal   (Followers: 5)
Journal of Sport & Tourism     Hybrid Journal   (Followers: 8)
Journal of Sustainable Tourism     Hybrid Journal   (Followers: 9)
Journal of Tourism and Cultural Change     Hybrid Journal   (Followers: 7)
Journal of Tourism Insights     Open Access  
Journal of Tourism Research & Hospitality     Partially Free  
Journal of Travel & Tourism Marketing     Hybrid Journal   (Followers: 9)
Journal of Travel Medicine     Hybrid Journal   (Followers: 1)
Journal of Travel Research     Hybrid Journal   (Followers: 14)
Journal of Unconventional Parks, Tourism & Recreation Research     Open Access  
Journal of Vacation Marketing     Hybrid Journal   (Followers: 3)
Mobilities     Hybrid Journal   (Followers: 2)
Multiciencias     Open Access  
PASOS Revista de Turismo y Patrimonio Cultural     Open Access  
Podium Sport, Leisure and Tourism Review     Open Access   (Followers: 2)
Polish Journal of Sport and Tourism     Open Access   (Followers: 2)
Provincia     Open Access  
Recreational Sport Journal     Hybrid Journal   (Followers: 5)
Research in Hospitality Management     Full-text available via subscription  
Revista de Gestão Ambiental e Sustentabilidade - GeAS     Open Access  
Revista de turism - studii si cercetari in turism     Open Access  
Revista Interamericana de Ambiente y Turismo     Open Access  
Revista Portuguesa e Brasileira de Gestão     Open Access  
Revista Rosa dos Ventos     Open Access   (Followers: 2)
Scandinavian Journal of Hospitality and Tourism     Hybrid Journal   (Followers: 4)
Space and Culture     Hybrid Journal   (Followers: 4)
Studies in Travel Writing     Hybrid Journal   (Followers: 5)
Téoros     Open Access  
The Rangeland Journal     Hybrid Journal   (Followers: 2)
Tourism     Open Access   (Followers: 2)
Tourism & Management Studies     Open Access  
Tourism Analysis     Full-text available via subscription   (Followers: 8)
Tourism and Hospitality Research     Hybrid Journal   (Followers: 6)
Tourism Culture & Communication     Full-text available via subscription   (Followers: 3)
Tourism Economics     Full-text available via subscription   (Followers: 4)
Tourism Geographies: An International Journal of Tourism Space, Place and Environment     Hybrid Journal   (Followers: 12)
Tourism in Marine Environments     Full-text available via subscription   (Followers: 2)
Tourism Management     Hybrid Journal   (Followers: 8)
Tourism Management Perspectives     Hybrid Journal   (Followers: 1)
Tourism Planning & Development     Hybrid Journal   (Followers: 9)
Tourism Review     Hybrid Journal  
Tourism Review International     Full-text available via subscription   (Followers: 3)
Tourist Studies     Hybrid Journal   (Followers: 4)
TRANSIT     Open Access  
Translation Studies     Hybrid Journal   (Followers: 13)
Worldwide Hospitality and Tourism Themes     Hybrid Journal   (Followers: 1)
Journal Cover Journal of Travel Medicine
   Journal TOC RSS feeds Export to Zotero [3 followers]  Follow    
   Hybrid Journal Hybrid journal (It can contain Open Access articles)
     ISSN (Print) 1195-1982 - ISSN (Online) 1708-8305
     Published by John Wiley and Sons Homepage  [1604 journals]   [SJR: 0.85]   [H-I: 36]
  • International Travel Patterns and Travel Risks for Stem Cell Transplant
           Recipients
    • Authors: Tarek Mikati; Kenneth Griffin, Dakotah Lane, Matthew Matasar, Monika K. Shah
      Pages: n/a - n/a
      Abstract: Background Stem cell transplantation (SCT) is being increasingly utilized for multiple medical illnesses. However, there is limited knowledge about international travel patterns and travel‐related illnesses of stem cell transplant recipients (SCTRs). Methods An observational cross‐sectional study was conducted among 979 SCTRs at Memorial Sloan Kettering Cancer Center using a previously standardized and validated questionnaire. International travel post SCT, pre‐travel health advice, exposure risks, and travel‐related illnesses were queried. Results A total of 516 SCTRs completed the survey (55% response rate); of these, 40% were allogeneic SCTRs. A total of 229 (44.3%) respondents reported international travel outside the United States and Canada post SCT. The international travel incidence was 32% [95% confidence interval CI 28–36] within 2 years after SCT. Using multivariable Cox regression analysis, variables significantly associated with international travel within first 2 years after SCT were history of international travel prior to SCT [hazard ratio (HR) = 5.3, 95% CI 2.3–12.0], autologous SCT (HR = 2.6, 95% CI 1.6–2.8), foreign birth (HR = 2.3, 95% CI 1.5–3.3), and high income (HR = 2.0, 95% CI 1.8–3.7). During their first trip, 64 travelers (28%) had traveled to destinations that may have required vaccination or malaria chemoprophylaxis. Only 56% reported seeking pre‐travel health advice. Of those who traveled, 16 travelers (7%) became ill enough to require medical attention during their first trip after SCT. Ill travelers were more likely to have visited high‐risk areas (60 vs 26%, p = 0.005), to have had a longer mean trip duration (24 vs 12 days, p = 0.0002), and to have visited friends and relatives (69 vs 21%, p 
      PubDate: 2014-10-17T04:42:37.64864-05:0
      DOI: 10.1111/jtm.12166
       
  • Leptospirosis After a Stay in Madagascar
    • Authors: Frédéric Pagès; Barbara Kuli, Marie‐Pierre Moiton, Cyrille Goarant, Marie‐Christine Jaffar‐Bandjee
      Pages: n/a - n/a
      Abstract: We report a case of polymerase chain reaction (PCR)‐confirmed leptospirosis in a patient who recently traveled to Madagascar, a country where only two cases have been reported since 1955. Although laboratory and clinical presentations were atypical and despite leptospirosis not being a documented disease in Madagascar, blood and urine tests for leptospirosis enabled retrospective confirmation of the diagnosis.
      PubDate: 2014-10-15T20:44:15.782856-05:
      DOI: 10.1111/jtm.12163
       
  • Rabies Postexposure Consultations in New Zealand from 1998 to 2012
    • Authors: Marc T.M. Shaw; Jenny Visser, Ciaran Edwards
      Pages: n/a - n/a
      Abstract: Background Rabies is an invariably fatal zoonotic viral disease. New Zealanders going abroad are largely unaware of the risk of contracting the disease. Prevention is the key to controlling the spread of this disease. Methods Data from 363 individuals presenting to New Zealand travel health clinics between 1998 and 2012 for post‐travel consultations on potential rabies exposure were collated retrospectively. The data focused on traveler demographics, the country and nature of exposure, the purpose of travel, and pre‐travel rabies awareness. Results The female‐to‐male ratio of subject travelers presenting was almost equal (1.1 : 1 ratio, respectively); the subjects were typically between 16 and 30 years (44.6%), tourists (64.5%), traveling less than 1 month (55.3%), and likely to have been exposed to animal contact in either Thailand (31.1%), China (13.2%), or Indonesia (12.3%). The animals to which they were exposed were usually dogs (59.5%) or monkeys (28.7%). Most potential exposures were penetrating (69.9%). Injury caused by the animal was more common in the lower limbs (50%) than in the upper limbs (43.4%); 89.4% of exposures were of World Health Organization (WHO) category III. Travelers were more likely to have received pre‐travel rabies advice if they had been seen by a travel medicine specialist (96.1%) compared to a general practitioner (GP) (53.3%). Sixteen percent of travelers received rabies preexposure prophylaxis. Of the subjects who were managed following exposure, 79.7% did not receive immunoglobulin when indicated, and 21.5% did not receive any vaccine. Of the travelers that did receive a vaccine, 62.5% did so on the day of exposure. Of the travelers assessed, 16.7% had traveled without insurance. Conclusions New Zealanders require better guidance in understanding the need for travel‐related rabies vaccination, as they are not managed abroad according to WHO guidelines. Few travelers had had pre‐travel immunization, and only 20.3% of them had received WHO‐advised postexposure management. Thus, 79.7% of the cohort theoretically remained at risk for contracting rabies because of inappropriate management following possible exposure to the disease.
      PubDate: 2014-10-15T01:36:09.396278-05:
      DOI: 10.1111/jtm.12167
       
  • Safety and Immunogenicity of Typhoid Fever and Yellow Fever Vaccines When
           Administered Concomitantly With Quadrivalent Meningococcal ACWY
           Glycoconjugate Vaccine in Healthy Adults
    • Authors: Martin Alberer; Gerd Burchard, Tomas Jelinek, Emil Reisinger, Jiri Beran, Lucie Cerna Hlavata, Eduardo Forleo‐Neto, Alemnew F. Dagnew, Ashwani K. Arora
      Pages: n/a - n/a
      Abstract: Background Compact and short pre‐travel immunization schedules, which include several vaccinations in a single visit, are desirable for many travelers. However, concomitant vaccination could potentially compromise immunogenicity and/or safety of the individual vaccines and, therefore, possible vaccine interferences should be carefully assessed. This article discusses the immunogenicity and safety of travel vaccines for typhoid fever (TF) and yellow fever (YF), when administered with or without a quadrivalent meningococcal glycoconjugate ACWY‐CRM vaccine (MenACWY‐CRM). Methods Healthy adults (18–≤60 years) were randomized to one of three vaccine regimens: TF + YF + MenACWY‐CRM (group I; n = 100), TF + YF (group II; n = 101), or MenACWY‐CRM (group III; n = 100). Immunogenicity at baseline and 4 weeks post‐vaccination (day 29) was assessed by serum bactericidal assay using human complement (hSBA), enzyme‐linked immunosorbent assay (ELISA), or a neutralization test. Adverse events (AEs) and serious adverse events (SAEs) were collected throughout the study period. Results Non‐inferiority of post‐vaccination geometric mean concentrations (GMCs) and geometric mean titers (GMTs) was established for TF and YF vaccines, respectively, when given concomitantly with MenACWY‐CRM vaccine versus when given alone. The percentages of subjects with seroprotective neutralizing titers against YF on day 29 were similar in groups I and II. The antibody responses to meningococcal serogroups A, C, W‐135, and Y were within the same range when MenACWY‐CRM was given separately or together with TF and YF vaccines. The percentage of subjects reporting AEs was the same for TF and YF vaccines with or without MenACWY‐CRM vaccine. There were no reports of SAEs or AEs leading to study withdrawals. Conclusions These data provide evidence that MenACWY‐CRM can be administered with typhoid Vi polysaccharide vaccine and live attenuated YF vaccine without compromising antibody responses stimulated by the individual vaccines. MenACWY‐CRM can, therefore, be incorporated into travelers' vaccination programs without necessitating an additional clinic visit (NCT01466387).
      PubDate: 2014-10-13T03:48:26.202878-05:
      DOI: 10.1111/jtm.12164
       
  • Schistosomiasis in Pregnant Travelers: A Case Series
    • Authors: Eli Ben‐Chetrit; Tamar Lachish, Kristine Mørch, Drorit Atias, Conor Maguire, Eli Schwartz
      Pages: n/a - n/a
      Abstract: Background Travel‐related acquisition of schistosomiasis in Africa is well established. Data concerning Schistosoma infection in pregnant travelers are lacking and treatment derives from studies in endemic regions. Methods This study was a retrospective case‐series of pregnant patients who were infected with Schistosoma species. Data regarding exposure history, clinical presentation, diagnosis, treatment, and fetal outcomes were collected and analyzed. Diagnosis of schistosomiasis was based on serology tests and/or ova recovery. Results Travel‐related schistosomiasis during pregnancy was diagnosed in 10 travelers (with 20 pregnancies). Of the 10 women, 4 pregnant travelers with recent exposure were treated during their pregnancy with praziquantel (PZQ). The course and outcome of pregnancy in these patients was uneventful, and treatment had no apparent adverse effects on either the mothers or their babies. Six asymptomatic women were diagnosed years after exposure. During this period, they gave birth to 13 babies. They were never treated with PZQ. Birth weights of their infants were significantly smaller as compared with those of the infants of the women who were treated during their pregnancy (median 2.8 vs 3.5 kg). One baby was born preterm. One patient had three miscarriages. Conclusion This is the first case‐series of pregnant travelers with schistosomiasis. Although a small case‐series with possible confounders, it suggests that schistosomiasis in pregnant travelers can be treated. A trend of lower birth weights was observed in the infants of the pregnant travelers who were not treated. PZQ therapy during pregnancy was not associated with adverse pregnancy or fetal outcomes in those four cases. Our results emphasize the importance of screening female travelers of childbearing age with a relevant history of freshwater exposure. Further studies are needed to reinforce these recommendations.
      PubDate: 2014-10-13T02:47:54.272229-05:
      DOI: 10.1111/jtm.12165
       
  • Serious Altitude Illness in Travelers Who Visited a Pre‐Travel
           Clinic
    • Authors: Mieke Croughs; Alfons Van Gompel, Sarah Rameckers, Jef Van den Ende
      Pages: n/a - n/a
      Abstract: Background Few data are available on the incidence and predictors of serious altitude illness in travelers who visit pre‐travel clinics. Travel health consultants advise on measures to be taken in case of serious altitude illness but it is not clear if travelers adhere to these recommendations. Methods Visitors to six travel clinics who planned to travel to an altitude of ≥3,000 m were asked to complete a diary from the first day at 2,000 m until 3 days after reaching the maximum sleeping altitude. Serious altitude illness was defined as having symptoms of serious acute mountain sickness (AMS score ≥ 6) and/or cerebral edema and/or pulmonary edema. Results The incidence of serious altitude illness in the 401 included participants of whom 90% reached ≥4,000 m, was 35%; 23% had symptoms of serious AMS, 25% symptoms of cerebral edema, and 13% symptoms of pulmonary edema. Independent predictors were young age, the occurrence of dark urine, travel in South America or Africa, and lack of acclimatization between 1,000 and 2,500 m. Acetazolamide was brought along by 77% of the responders of whom 41% took at least one dose. Of those with serious altitude illness, 57% had taken at least one dose of acetazolamide, 20% descended below 2,500 m on the same day or the next, and 11% consulted a physician. Conclusions Serious altitude illness was a very frequent problem in travelers who visited pre‐travel clinics. Young age, dark urine, travel in South America or Africa, and lack of acclimatization nights at moderate altitude were independent predictors. Furthermore, we found that seriously ill travelers seldom followed the advice to descend and to visit a physician.
      PubDate: 2014-09-19T04:45:20.152231-05:
      DOI: 10.1111/jtm.12160
       
  • A Case of Melioidosis Probably Acquired by Inhalation of Dusts During a
           Helicopter Flight in a Healthy Traveler Returning From Singapore
    • Authors: Silvia Amadasi; Sarah Dal Zoppo, Annalisa Bonomini, Anna Bussi, Palmino Pedroni, Gianpaolo Balestrieri, Liana Signorini, Francesco Castelli
      Pages: n/a - n/a
      Abstract: We present a case of melioidosis in an Italian male returning from Singapore after a short travel. He probably acquired the disease by inhalation, which is not the typical mode of transmission, in the absence of evident risk factors. The diagnosis was confirmed by real‐time polymerase chain reaction of the culture while serology was useful to assess professional exposure among laboratory workers. Treatment consisted of an initial intensive phase with meropenem and trimethoprim–sulfamethaxazole (TMP–SMX), followed by 6 months of eradication therapy with TMP–SMX.
      PubDate: 2014-09-02T21:59:02.630486-05:
      DOI: 10.1111/jtm.12150
       
  • Optic Neuritis in a Traveler Returning From Dominican Republic to Spain
           With Dengue Virus Infection
    • Authors: José M. Ramos; Antonio Tello, Antonio Alzamora, María Luisa Ramón
      Pages: n/a - n/a
      Abstract: A search of medical literature will show that dengue infection is rarely linked to optic neuritis. Here we report the development of loss of vision in a female traveler who returned to Spain from the Caribbean after acquiring a dengue infection.
      PubDate: 2014-08-29T04:21:37.619896-05:
      DOI: 10.1111/jtm.12157
       
  • Chikungunya: Acute Fever, Rash and Debilitating Arthralgias in a Returning
           Traveler From Haiti
    • Authors: Kathryn B. Anderson; Vincent Pureza, Patricia F. Walker
      Pages: n/a - n/a
      Abstract: The following case report details a case of chikungunya fever in a returning traveler from Haiti. The report highlights the clinical presentation and natural history of the disease, and emphasizes that chikungunya has become established in the western hemisphere, with a resultant need for heightened provider awareness.
      PubDate: 2014-08-28T20:52:33.561442-05:
      DOI: 10.1111/jtm.12159
       
  • Red Herring in Returned Traveler: Drug Reaction With Eosinophilia and
           Systemic Symptom (DRESS) Syndrome Mimicking Sepsis
    • Authors: Hui Yin Lim; Gene Khai Lin Huang, Joseph Torresi, Douglas Johnson
      Pages: n/a - n/a
      Abstract: We report a case of a 51‐year‐old Han Chinese recently returned traveler, who was admitted with a generalized maculopapular rash, fevers, shock, and multi‐organ failure. Extensive investigations failed to reveal an infective cause. Skin biopsy findings together with the recent commencement of allopurinol raised a diagnosis of drug reaction with eosinophilia and systemic symptom syndrome. High‐dose prednisolone was commenced and the patient made a rapid recovery. This case highlights that not all sepsis‐like presentations in returned travelers are due to infective causes and that severe drug reactions need to be considered in the differential diagnosis.
      PubDate: 2014-08-28T20:48:36.537102-05:
      DOI: 10.1111/jtm.12152
       
  • Carybdea marsupialis (Cubozoa) in the Mediterranean Sea: The First Case of
           a Sting Causing Cutaneous and Systemic Manifestations
    • Authors: Cesar Bordehore; Santiago Nogué, Josep‐Maria Gili, Melissa J. Acevedo, Verónica L. Fuentes
      Pages: n/a - n/a
      Abstract: A woman stung by the box jellyfish Carybdea marsupialis (Cnidaria, Cubozoa) at a Spanish Mediterranean beach showed systemic manifestations over several months [pain far from the inoculation point, arthralgia, paresthesia, hyperesthesia, increase in eosinophils and immunoglobulin E (IgE)] in addition to the skin condition.
      PubDate: 2014-08-28T03:18:25.17583-05:0
      DOI: 10.1111/jtm.12153
       
  • Dengue‐Associated Hemophagocytic Syndrome in a Japanese Traveler: A
           Case Report
    • Authors: Ken‐ichiro Kobayashi; Mayu Hikone, Naoya Sakamoto, Sentaro Iwabuchi, Masahiro Kashiura, Tomohiko Takasaki, Hiroshi Fujita, Kenji Ohnishi
      Pages: n/a - n/a
      Abstract: Hemophagocytic syndrome (HPS) can develop as a complication of dengue in rare cases, but its relationship with dengue is not well known. We report a case of dengue‐associated HPS with liver involvement and coagulopathy. The patient, a Japanese female traveler who had recently returned from Thailand, had severe complications of dengue infection, but she recovered fully with symptomatic treatment.
      PubDate: 2014-08-27T03:14:08.628431-05:
      DOI: 10.1111/jtm.12158
       
  • Intent‐to‐Adhere and Adherence to Malaria Prevention
           Recommendations in Two Travel Clinics
    • Authors: Irit Goldstein; Rami Grefat, Moshe Ephros, Shmuel Rishpon
      Pages: n/a - n/a
      Abstract: Malaria infects 30,000 travelers annually worldwide. At greatest risk are those who travel for long duration. Prevention of malaria includes chemoprophylaxis. This prospective study on 121 travelers who visited two travel clinics shows that adherence to prophylactic treatment was low, especially in long duration trips, and that adherence rate could be predicted by the much more available intent‐to‐adhere rate.
      PubDate: 2014-08-27T03:13:00.277193-05:
      DOI: 10.1111/jtm.12156
       
  • Preparing Children for International Travel: Need for Training and
           Pediatric‐Focused Research
    • Authors: Stefan H.F. Hagmann; Eyal Leshem, Philip R. Fischer, William M. Stauffer, Elizabeth D. Barnett, John C. Christenson
      Pages: n/a - n/a
      Abstract: Background The International Society of Travel Medicine (ISTM) Pediatric Interest Group (PedIG) was created in 2010. We studied the group's professional characteristics and practice patterns to identify clinical areas requiring further training and research related to pediatric international travel. Methods PedIG members were emailed a two‐part online questionnaire in September 2011, which comprised questions about professional and practice details, followed by a survey regarding decisions on nine patient scenarios that represent common pediatric pre‐travel health challenges. Results Ninety‐three (34%) of 273 members completed the survey. Most were physicians (80%) having a primary specialization in pediatrics (55%) and family medicine (19%). About a third (37%) had acquired the ISTM Certificate in Travel Health® (CTH®); 14 and 11% chose not to provide malaria chemoprophylaxis for a 2‐month‐old infant and a 13‐year‐old child traveling to West Africa, respectively. Azithromycin for empiric treatment of travelers' diarrhea in a 2‐year‐old traveler to Thailand and Mexico was suggested by 74 and 58%, respectively, while the use of acetazolamide for a 2‐month old infant traveling to a high‐altitude destination was rarely (13%) chosen. In vaccine‐focused scenarios, 71, 69, 21, and 10% would prescribe the meningococcal vaccine for a 6‐month‐old traveler to Burkina Faso, Japanese encephalitis vaccine to a 10‐year‐old traveler to Cambodia, hepatitis A vaccine to a 6‐month‐old traveler to El Salvador, and the typhoid vaccine to a 1‐year‐old traveler to India, respectively. Conclusions Members of the PedIG have diverse professional and practice backgrounds. Lack of awareness of established guidelines may place international pediatric travelers at risk for travel‐associated morbidity. Strategies are needed to facilitate education and support research in pediatric travel medicine to formulate evidence‐based guidelines wherever they are currently missing.
      PubDate: 2014-08-27T03:10:38.541584-05:
      DOI: 10.1111/jtm.12155
       
  • Noneruptive Fever Revealing Murine Typhus in a Traveler Returning From
           Tunisia
    • Authors: Laura Gastellier; Fanny Lanternier, Aurélie Renvoisé, Sébastien Rivière, Didier Raoult, Olivier Lortholary, Marc Lecuit
      Pages: n/a - n/a
      Abstract: Rickettsia species are increasingly being recognized as a cause of infection among returning travelers. Murine typhus (MT) was mistakenly thought to have disappeared in the 1970s in Tunisia, yet recent serological data show that Rickettsia typhi, the causative agent of MT, still circulates in the Tunisian population. We report here a case of MT in a woman returning from Tunisia and hospitalized in France. Her presentation was nonspecific, with acute noneruptive fever. Diagnosis was confirmed by cross‐adsorption and immunoblotting. Clinicians taking care of returning travelers with fever should be aware of MT, and know how to diagnose and treat it.
      PubDate: 2014-08-27T02:44:38.738714-05:
      DOI: 10.1111/jtm.12154
       
  • Recurrent Furunculosis in Returning Travelers: Newly Defined Entity
    • Authors: Ofir Artzi; Maya Sinai, Michal Solomon, Eli Schwartz
      Pages: n/a - n/a
      Abstract: Background Bacterial skin infection is a common dermatologic problem in travelers, which usually resolves without sequela. In contrast, post‐travel recurrent furunculosis (PTRF) is a new unique entity of a sequential occurrence of many furuncles seen after returning home from a trip to the Tropics. Objective The objective of this study was to characterize the disease course and possible causes of PTRF. Methods A retrospective study was conducted on a group of young, healthy individuals (16 males and 5 females), who presented with PTRF after returning from tropical countries. Results In all patients, the first furuncle appeared toward the end of the trip and continued for several months after returning home. The average duration of disease was 8.4 months with an average of 4.2 recurrences. Along the disease course, subsequent recurrences became shorter and milder with longer inter‐recurrence intervals. Bacterial cultures most commonly grew methicillin‐sensitive Staphylococcus aureus (MSSA, 76.5%). Nasal colonization was demonstrated in 47% of patients. There were neither companion travelers nor family members experiencing furuncles. Conclusions PTRF should be defined as a clinical entity with prolonged travel to the Tropics being its major risk factor. In the author's opinion, a transient immune change in a subpopulation of travelers ignites a series of recurrent furuncles, resolving upon restoration of normal immunity.
      PubDate: 2014-08-25T03:46:05.969691-05:
      DOI: 10.1111/jtm.12151
       
  • Advice on Malaria and Yellow Fever Prevention Provided at Travel Agencies
           in Cuzco, Peru
    • Authors: Pablo G. Villanueva‐Meyer; Carlos A. Garcia‐Jasso, Chelsea A. Springer, Jenna K. Lane, Bonny S. Su, Idania S. Hidalgo, Mary R. Goodrich, Emily L. Deichsel, A. C. White, Miguel M. Cabada
      Pages: n/a - n/a
      Abstract: Background Travelers receive medical advice from a variety of sources, including travel agencies. The aim of this study is to describe the quality of pre‐travel advice provided by travel agencies in Cuzco to travelers interested in visiting malaria and yellow fever endemic areas. Methods Trained medical students posed as tourists and visited travel agencies in Cuzco requesting travel advice for a trip to the southern Amazon of Peru, recording advice regarding risk and prevention of malaria and yellow fever. Results A total of 163 registered travel agencies were included in the study. The mean proposed tour duration was 6.8 days (±1.4 days) with a median time to departure of 3 days and a median tour cost of 805 US dollars (USD) [interquartile range (IQR) 580–1,095]. Overall, 45% employees failed to mention the risk for any illness. Eighteen percent of the employees acknowledged risk of malaria and 53% risk of yellow fever. However, 36% denied malaria risk and 2% denied risk of yellow fever in the region. The price of tours from travel agencies that did not mention any health risk was significantly lower [1,009.6 ± 500.5 vs 783.9 ± 402 USD, t (152) = 3, p 
      PubDate: 2014-08-25T03:24:18.708232-05:
      DOI: 10.1111/jtm.12149
       
  • What Do We Know About Medical Tourism? A Review of the Literature With
           Discussion of Its Implications for the UK National Health Service as an
           Example of a Public Health Care System
    • Authors: Johanna Hanefeld; Richard Smith, Daniel Horsfall, Neil Lunt
      Pages: n/a - n/a
      Abstract: Background Medical tourism is a growing phenomenon. This review of the literature maps current knowledge and discusses findings with reference to the UK National Health Service (NHS). Methods Databases were systematically searched between September 2011 and March 2012 and 100 papers were selected for review. Results The literature shows specific types of tourism depending on treatment, eg, dentistry, cosmetic, or fertility. Patient motivation is complex and while further research is needed, factors beyond cost, including availability and distance, are clearly important. The provision of medical tourism varies. Volume of patient travel, economic cost and benefit were established for 13 countries. It highlights contributions not only to recipient countries' economies but also to a possible growth in health systems' inequities. Evidence suggests that UK patients travel abroad to receive treatment, complications arise and are treated by the NHS, indicating costs from medical travel for originating health systems. Conclusion It demonstrates the importance of quality standards and holds lessons as the UK and other EU countries implement the EU Directive on cross‐border care. Lifting the private‐patient‐cap for NHS hospitals increases potential for growth in inbound medical tourism; yet no research exists on this. Research is required on volume, cost, patient motivation, industry, and on long‐term health outcomes in medical tourists.
      PubDate: 2014-08-25T02:41:15.607673-05:
      DOI: 10.1111/jtm.12147
       
  • Influenza Vaccination Among Australian Hajj Pilgrims: Uptake, Attitudes,
           and Barriers
    • Authors: Osamah Barasheed; Harunor Rashid, Leon Heron, Iman Ridda, Elizabeth Haworth, Jonathan Nguyen‐Van‐Tam, Dominic E. Dwyer, Robert Booy,
      Pages: n/a - n/a
      Abstract: Background Hajj is the largest annual mass gathering where the risk of respiratory infection is high. Although the Saudi Arabian authority recommends influenza vaccination for Hajj pilgrims, the uptake is variable. Influenza vaccine uptake data among Australian Hajj pilgrims is not readily available. Therefore, we aimed to estimate the influenza vaccination uptake rate and identify both attitudes and barriers to vaccine uptake from two consecutives surveys at Hajj in 2011 and 2012. Methods Using an anonymous self‐administered questionnaire, surveys were conducted in Mecca, Saudi Arabia, among Hajj pilgrims from Australia in 2011 and 2012. Pilgrims staying in “Australian” tents were recruited serially. Results In 2011, 431 Australian pilgrims completed the survey—median age was 42 (range 7–86) years, 55% were male; 65% reported receiving influenza vaccine. In 2012, 535 pilgrims of median age 43 (range 12–83) years completed the survey, 62% were male; 89% reported receiving the vaccine. Both in 2011 and 2012, common reasons for not receiving the vaccine were the pilgrims' reliance on their “natural immunity” (33 and 26%, respectively, p = 0.4) and believing that they would rarely catch influenza or come in contact with influenza patients (18 and 29%, respectively, p = 0.1). In 2012, when asked why they had received the vaccine, 65% pilgrims responded that it was because of the tour group leaders' recommendation. Conclusion Influenza vaccine uptake among Australian Hajj pilgrims seems satisfactory and increasing but could be better because many pilgrims have misconceptions about vaccines. Tour operators may play a greater role in promoting vaccination.
      PubDate: 2014-08-21T22:21:37.679339-05:
      DOI: 10.1111/jtm.12146
       
  • Visceral Leishmaniasis‐Associated Hemophagocytic Lymphohistiocytosis
           in a Traveler Returning From a Pilgrimage to the Camino de Santiago
    • Authors: Emily R. Watkins; Sriram Shamasunder, Thomas Cascino, Kristie L. White, Shereen Katrak, Caryn Bern, Brian S. Schwartz
      Pages: n/a - n/a
      Abstract: We report the case of a 73‐year‐old American traveler who presented with 3 weeks of fatigue, fevers, chills, and pancytopenia. Clinical and laboratory findings were consistent with hemophagocytic lymphohystiocytosis (HLH) and bone marrow biopsy revealed amastigotes consistent with visceral leishmaniasis. The range of endemic visceral leishmaniasis transmission now extends into northern Spain and travelers to this region should use personal protective measures against sand fly exposure.
      PubDate: 2014-08-21T22:17:44.018886-05:
      DOI: 10.1111/jtm.12145
       
  • Travelers With Sickle Cell Disease
    • Authors: Shaina M. Willen; Courtney D. Thornburg, Paul M. Lantos
      Pages: n/a - n/a
      Abstract: Background Sickle cell disease (SCD) is the most common genetic disease among persons with African ancestry. This article provides a background to SCD and reviews many important aspects of travel preparation in this population. Methods The medical literature was searched for studies on travel-associated preparedness and complications in individuals with SCD. Topics researched included malaria, bacterial infections, vaccinations, dehydration, altitude, air travel, and travel preparedness. Results There is very little published literature that specifically addresses the risks faced by travelers with SCD. Rates of medical complications during travel appear to be high. There is a body of literature that describes complications of SCD in indigenous populations, particularly within Africa. The generalizability of these data to a traveler is uncertain. Combining these sources of data and the broader medical literature, we address major travel-related questions that may face a provider preparing an individual with SCD for safe travel. Conclusions Travelers with SCD face considerable medical risks when traveling to developing tropical countries, including malaria, bacterial infections, hypovolemia, and sickle cell-associated vaso-occlusive crises. For individuals with SCD, frank counseling about the risks, vigilant preventative measures, and contingency planning for illness while abroad are necessary aspects of the pre-travel visit.
      PubDate: 2014-06-19T22:48:01.128282-05:
      DOI: 10.1111/jtm.12142
       
  • A Profile of Travelers—An Analysis From a Large Swiss Travel Clinic
    • Authors: Silja Bühler; Rolanda Rüegg, Robert Steffen, Christoph Hatz, Veronika K. Jaeger
      Pages: n/a - n/a
      Abstract: Background Globally, the Swiss have one of the highest proportions of the population traveling to tropical and subtropical countries. Large travel clinics serve an increasing number of customers with specific pre-travel needs including uncommon destinations and preexisting medical conditions. This study aims to identify health characteristics and travel patterns of travelers seeking advice in the largest Swiss travel clinic so that tailored advice can be delivered. Methods A descriptive analysis was performed on pre-travel visits between July 2010 and August 2012 at the Travel Clinic of the Institute of Social and Preventive Medicine, University of Zurich, Switzerland. Results A total of 22,584 travelers sought pre-travel advice. Tourism was the main reason for travel (17,875, 81.5%), followed by visiting friends and relatives (VFRs; 1,715, 7.8%), traveling for business (1,223, 5.6%), and “other reasons” (ie, volunteer work, pilgrimage, study abroad, and emigration; 1,112, 5.1%). The main travel destination was Thailand. In the VFR group, the highest proportions of traveling children (258, 15.1%) and of pregnant or breastfeeding women (23, 3.9%) were observed. Mental disorders were more prominent in VFRs (93, 5.4%) and in travel for “other reasons” (63, 5.7%). The latter stayed for the longest periods abroad; 272 (24.9%) stayed longer than 6 months. VFR travelers received the highest percentage of yellow fever vaccinations (523, 30.5%); in contrast, rabies (269, 24.2%) and typhoid vaccinations (279, 25.1%) were given more often to the “other travel reasons” group. Conclusions New insights into the characteristics of a selected and large population of Swiss international travelers results in improved understanding of the special needs of an increasingly diverse population and, thus, in targeted preventive advice and interventions.
      PubDate: 2014-06-16T23:25:09.357557-05:
      DOI: 10.1111/jtm.12139
       
  • A Case Suspected for Yellow Fever Vaccine-Associated Viscerotropic Disease
           in the Netherlands
    • Authors: Eva M. van de Pol; Elizabeth H. Gisolf, Clemens Richter
      Abstract: Yellow fever (YF) 17D vaccine is one of the most successful vaccines ever developed. Since 2001, 56 cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) have been published in the peer-reviewed literature. Here, we report a new case suspected for YEL-AVD in the Netherlands. Further research is needed to determine the true incidence of YEL-AVD and to clarify host and vaccine-associated factors in the pathogenesis of YEL-AVD. Because of the potential adverse events, healthcare providers should carefully consider vaccination only in people who are truly at risk for YF infection, especially in primary vaccine recipients.
      PubDate: 2014-06-11T22:48:34.963426-05:
      DOI: 10.1111/jtm.12135
       
  • Health Risks of Young Adult Travelers With Type 1 Diabetes
    • Authors: Yael Levy-Shraga; Uri Hamiel, Marianna Yaron, Orit Pinhas-Hamiel
      Abstract: Aim International travel has become popular among young adults. This study evaluated the rate and characteristics of travel-associated health risks among young adults with type 1 diabetes mellitus (T1DM) compared with healthy same-aged individuals. Methods A retrospective study was conducted of 47 young adults with T1DM and 48 without (controls). Structured questionnaires accessed information regarding 154 international trips during the preceding 5 years and lasted 7 days and longer. Results Mean ± SD ages of the diabetic and control groups were 26.6 ± 5.0 and 26.9 ± 2.6 years, respectively. Mean trip durations were 80.0 (range 7.0–390.0) and 87.6 days (range 7.0–395.0), respectively. The number of trips per person was 1.5 ± 0.6 and 1.7 ± 0.8, and the proportion of trips to developing countries 64 and 61%, respectively. There were no differences between the groups in rates of travel-related diseases that required medical consultation (11% vs 15% for all trips). No patient sought medical attention for acute problems related to diabetes management. Prior to 71% of their trips to developing countries, respondents with diabetes consulted their diabetes physician; prior to 26% of their trips they switched from an insulin pump to injections; during 41% of the trips they increased glucose monitoring; and for the period of 11% of the trips they defined their metabolic control as poor. Self-reported mean hemoglobin A1c (HbA1c) levels before and after trips were 7.65 ± 1.45 and 7.81 ± 1.23%, respectively (p = 0.42, paired t-test). Conclusions Young adults with type 1 diabetes did not report more travel-related diseases than did healthy individuals. Most reported reasonable to good glycemic control during the trip without severe consequences.
      PubDate: 2014-06-09T05:01:01.732026-05:
      DOI: 10.1111/jtm.12136
       
  • Three Cases of Imported Dengue Virus Infection From Madeira to Belgium,
           2012
    • Authors: Lieselotte Cnops; Leticia Franco, Britt Van Meensel, Jef Van den Ende, Maria Paz Sanchez‐Seco, Marjan Van Esbroeck
      Pages: n/a - n/a
      Abstract: We report three laboratory‐confirmed dengue virus (DENV) infections imported to Belgium by travelers returning from Madeira (Portugal). Despite the use of a mosquito‐repellent spray as reported by two patients, the infection could not be prevented. Diagnosis was made by antigen detection and real‐time reverse transcriptase polymerase chain reaction (RT‐PCR) in two cases and by serology 1 month after onset of symptoms in a third one. The responsible virus was identified as DENV serotype 1, American/African genotype (genotype V). The close relationship to isolates from Colombia supports the previous findings that a South American strain originated the outbreak in Madeira in 2012.
      PubDate: 2014-03-13T03:01:56.88213-05:0
      DOI: 10.1111/jtm.12113
       
  • Tracking the Traveler Without a Passport: Perspective on Surveillance of
           Imported Disease
    • Authors: Koya C. Allen
      Pages: 295 - 297
      PubDate: 2014-08-25T03:32:46.160275-05:
      DOI: 10.1111/jtm.12143
       
  • Influenza B Outbreak on a Cruise Ship off the São Paulo Coast, Brazil
    • Authors: Eder G. Fernandes; Priscila B. de Souza, Maria Emília B. de Oliveira, Gisele D.F. Lima, Alessandra Cristina G. Pellini, Manoel Carlos S.A. Ribeiro, Helena K. Sato, Ana F. Ribeiro, Ana Lucia F. Yu
      First page: 298
      Abstract: Background In February 2012, crew and passengers of a cruise ship sailing off the coast of São Paulo, Brazil, were hospitalized for acute respiratory illness (ARI). A field investigation was performed to identify the disease involved and factors associated. Methods Information on passengers and crew with ARI was obtained from the medical records of hospitalized individuals. Active case finding was performed onboard the ship. ARI was defined as the presence of one nonspecific symptom (fever, chills, myalgia, arthralgia, headache, or malaise) and one respiratory symptom (cough, nasal congestion, sore throat, or dyspnea). A case–control study was conducted among the crew. The cases were crew members with symptoms of influenza-like illness (ILI) (fever and one of the following symptoms: cough, sore throat, and dyspnea) in February 2012. The controls were asymptomatic crew members. Results The study identified 104 ARI cases: 54 (51.9%) crew members and 50 (49.1%) passengers. Among 11 ARI hospitalized cases, 6 had influenza B virus isolated in nasopharyngeal swab. One mortality among these patients was caused by postinfluenza Staphylococcus aureus pneumonia. The crew members housed in the two lower decks and those belonging to the 18- to 32-year-old age group were more likely to develop ILI [odds ratio (OR) = 2.39, 95% confidence interval (CI) 1.09–5.25 and OR = 3.72, CI 1.25–11.16, respectively]. Conclusions In February 2012, an influenza B outbreak occurred onboard a cruise ship. Among crew members, ILI was associated with lower cabin location and younger age group. This was the first influenza outbreak detected by Brazilian public health authorities in a vessel cruising in South American waters.
      PubDate: 2014-06-03T04:37:35.933437-05:
      DOI: 10.1111/jtm.12132
       
  • Travel-Related Shigellosis in Quebec, Canada: An Analysis of Risk Factors
    • Authors: Stéphane Trépanier; Yen-Giang Bui, Manon Blackburn, François Milord, Éric Levac, Suzanne Gagnon
      First page: 304
      Abstract: Background Travel-related shigellosis is not well documented in Canada although it is frequently acquired abroad and can cause severe disease. Objectives To describe the epidemiology of travel-related cases of shigellosis for Quebec (Canada) and to identify high-risk groups of travelers. Method and Data Sources We performed a random sampling of 335 shigellosis cases (from a total of 760 cases) reported in the provincial database of reportable diseases from January 1, 2004, to December 31, 2007. Each case was analyzed according to information available in the epidemiology questionnaire. Total number of trips by region from Statistics Canada was used as denominator to estimate the risk according to region of travel. Results Annually, between 43 and 54% of the shigellosis cases were reported in travelers, 45% of whom were aged between 20 and 44 years. Children under 11 years accounted for nearly 16% of cases, but represent only 4% of travelers. Most cases in travelers were serogroups Shigella sonnei (50%) or Shigella flexneri (45%). Almost 31% of cases were reported between January and March. The majority (64%) were acquired in Central America, Mexico, or the Caribbean. However, the Indian subcontinent, Africa, and South America had the highest ratio of number of cases per number of trips. Tourists represented 76% of the cases; 62% of them had traveled for
      PubDate: 2014-06-03T02:51:35.419123-05:
      DOI: 10.1111/jtm.12130
       
  • A Case Series of Three US Adults With Japanese Encephalitis,
           2010–2012
    • Authors: Susan L. Hills; Juliet Stoltey, Diana Martínez, Paul Y. Kim, Heather Sheriff, Ana Zangeneh, Sally R. Eilerman, Marc Fischer
      First page: 310
      Abstract: Background Japanese encephalitis (JE) virus is the leading cause of vaccine-preventable encephalitis in Asia. Although the risk for acquiring JE for most travelers to Asia is low, it varies based on the destination, season, trip duration, and activities. Methods We present case reports of three US adults who were infected with JE virus while traveling or residing in Asia. Results Among the three JE patients, the first made a 10-day trip to mainland China and participated in outdoor activities in a rural area, the second had been resident in Taiwan for 4 months, and the third, fatal case was an expatriate living in South Korea. Conclusions JE should be considered in the differential diagnosis for any patient with an acute neurologic infection, who has recently been in a JE-endemic country. Health-care providers should assess the itineraries of travelers to JE-endemic countries, provide guidance on personal protective measures to prevent vector-borne diseases, and consider recommending JE vaccine for travelers at increased risk for JE virus infection.
      PubDate: 2014-05-26T03:30:32.38278-05:0
      DOI: 10.1111/jtm.12127
       
  • Imported Plasmodium vivax Malaria ex Pakistan
    • Authors: Silvia Odolini; Philippe Gautret, Kevin C. Kain, Kitty Smith, Karin Leder, Mogens Jensenius, Christina M. Coyle, Francesco Castelli, Alberto Matteelli
      First page: 314
      Abstract: Background According to WHO, 1.5 million cases of malaria are reported annually in Pakistan. Malaria distribution in Pakistan is heterogeneous, and some areas, including Punjab, are considered at low risk for malaria. The aim of this study is to describe the trend of imported malaria cases from Pakistan reported to the international surveillance systems from 2005 to 2012. Methods Clinics reporting malaria cases acquired after a stay in Pakistan between January 1, 2005, and December 31, 2012, were identified from the GeoSentinel ( http://www.geosentinel.org) and EuroTravNet ( http://www.Eurotravnet.eu) networks. Demographic and travel-related information was retrieved from the database and further information such as areas of destination within Pakistan was obtained directly from the reporting sites. Standard linear regression models were used to assess the statistical significance of the time trend. Results From January 2005 to December 2012, a total of 63 cases of malaria acquired in Pakistan were retrieved in six countries over three continents. A statistically significant increasing trend in imported Plasmodium vivax malaria cases acquired in Pakistan, particularly for those exposed in Punjab, was observed over time (p = 0.006). Conclusions Our observation may herald a variation in malaria incidence in the Punjab province of Pakistan. This is in contrast with the previously described decreasing incidence of malaria in travelers to the Indian subcontinent, and with reports that describe Punjab as a low risk area for malaria. Nevertheless, this event is considered plausible by international organizations. This has potential implications for changes in chemoprophylaxis options and reinforces the need for increased surveillance, also considering the risk of introduction of autochthonous P. vivax malaria in areas where competent vectors are present, such as Europe.
      PubDate: 2014-06-03T04:44:45.605752-05:
      DOI: 10.1111/jtm.12134
       
  • Emergency Medical Equipment On Board German Airliners
    • Authors: Jochen Hinkelbein; Christopher Neuhaus, Wolfgang A. Wetsch, Oliver Spelten, Susanne Picker, Bernd W. Böttiger, Birgit S. Gathof
      First page: 318
      Abstract: Background Medical emergencies often occur on commercial airline flights, but valid data on their causes and consequences are rare. Therefore, it is unclear what emergency medical equipment is necessary. Although a minimum standard for medical equipment is defined in regulations, additional material is not standardized and may vary significantly between different airlines. Methods German airlines operating aircrafts with more than 30 seats were selected and interviewed with a 5-page written questionnaire between August 2011 and January 2012. Besides pre-packed and required emergency medical material, drugs, medical devices, and equipment lists were queried. If no reply was received, airlines were contacted another three times by e-mail and/or phone. Descriptive analysis was used for data presentation and interpretation. Result From a total of 73 German airlines, 58 were excluded from analysis (eg, those not providing passenger transport). Fifteen airlines were contacted and data of 13 airlines were available for analysis (two airlines did not participate). A first aid kit was available on all airlines. Seven airlines reported having a doctor's kit, and another four provided an “emergency medical kit.” Four airlines provided an automated external defibrillator (AED)/electrocardiogram (ECG). While six airlines reported providing anesthesia drugs, a laryngoscope, and endotracheal tubes, another four airlines did not provide even a resuscitator bag. One airline did not provide any material for cardiopulmonary resuscitation (CPR). Conclusions Although the minimal material required according to European aviation regulations is provided by all airlines for medical emergencies, there are significant differences in the provision of additional material. The equipment on most airlines is not sufficient for the treatment of specific emergencies according to published medical guidelines (eg, for CPR or acute myocardial infarction).
      PubDate: 2014-06-05T23:57:09.504683-05:
      DOI: 10.1111/jtm.12138
       
  • Imported Dengue Fever in Tuscany, Italy, in the Period 2006 to 2012
    • Authors: Filippo Lagi; Lorenzo Zammarchi, Marianne Strohmeyer, Filippo Bartalesi, Antonia Mantella, Massimo Meli, Pierluigi Blanc, Danilo Tacconi, Alberto Farese, Giacomo Zanelli, Francesco Pippi, Donatella Aquilini, Aniello Tonziello, Cesira Nencioni, Maria Benvenuti, Sara Moneta, Franca Furnari, Maria G. Ciufolini, Loredana Nicoletti, Alessandro Bartoloni
      Pages: 340 - 343
      Abstract: This report focuses on epidemiological and clinical features of dengue fever (DF) in Tuscany (Italy) between 2006 and 2012. Sixty‐one DF cases were diagnosed, 32 of which were in the period of Aedes albopictus activity. Some clinical (arthralgia/myalgia, nausea/vomiting, and skin rash), laboratory (leukopenia and thrombocytopenia), and epidemiological characteristics (travel in a continent other than Africa) significantly distinguished DF cases from other febrile illnesses. Our data stress the importance of increasing awareness on dengue in Italy among clinicians in order to reach an early diagnosis in returning travelers and to implement appropriate clinical and public health interventions.
      PubDate: 2014-08-25T03:32:39.576765-05:
      DOI: 10.1111/jtm.12144
       
  • The Visiting Internet Fiancé/ée (VIF): An Emerging Group of
           International Travelers
    • Authors: Theresa A. Sofarelli; Holly K. Birich, DeVon C. Hale
      First page: 349
      Abstract: Here we describe an emerging category of travelers called the Visiting Internet Fiancé/ée (VIF), characterized by their travel to pursue a romantic relationship with an individual they have only encountered online. The VIF is not well identified in travel medicine literature despite having a higher risk for several travel-related issues including sexually transmitted infections, monetary fraud, and international scams. We also propose specific counseling interventions designed to minimize the adverse outcomes faced by the VIF traveler.
      PubDate: 2014-05-28T21:16:23.371738-05:
      DOI: 10.1111/jtm.12128
       
  • Hepatitis B Surface Antigen Positivity After Twinrix Vaccination:
           A Case Report
    • Authors: Yirang Lee; Jae-Seok Kim, Ji-Young Park, Soo Young Kim, In Hong Hwang, Hyoun Chan Cho
      First page: 352
      Abstract: Travelers might have an increased risk of hepatitis B virus (HBV) infection. We report a case of prolonged transient hepatitis B surface antigenemia in a healthy Canadian female 8 days after administration of a combined hepatitis A and hepatitis B vaccine. Travel health providers providing hepatitis B vaccines need to be aware of this phenomenon and educate their patients accordingly.
      PubDate: 2014-05-26T01:58:28.961443-05:
      DOI: 10.1111/jtm.12129
       
  • The Burden of Imported Malaria in Portugal 2003 to 2012
    • Authors: Ana Glória Fonseca; Sara S. Dias, Joao Luis Baptista, Jorge Torgal
      First page: 354
      Abstract: Increasing international travel and expatriation to sub-Saharan countries where malaria is endemic has raised public health concerns about the burden of imported malaria cases in Portugal. From 2009 to 2012, there was a 60% increase in malaria hospitalizations, contradicting the declining trend observed since 2003. Older age was associated with longer length of stay in hospital and higher lethality.
      PubDate: 2014-06-13T02:12:59.620759-05:
      DOI: 10.1111/jtm.12141
       
  • Plasmodium knowlesi: Clinical Presentation and Laboratory Diagnosis of the
           First Human Case in a Scottish Traveler
    • Authors: Claire J. Cordina; Richard Culleton, Brian L. Jones, Catherine C. Smith, Alisdair A. MacConnachie, Michael J. Coyne, Claire L. Alexander
      First page: 357
      Abstract: The first imported case of Plasmodium knowlesi in Scotland is described in a 33-year-old female with a travel history to Borneo. The patient ceased to take antimalarial prophylaxis after 4 days of her 10-day visit and presented with a history of fever, rigor, vomiting, and diarrhea after 13 days on her return to the UK. Malaria antigen detection using the Optimal-IT and Binax-NOW kits was negative. Unusual trophozoite-like structures were observed under microscopic examination and the identification of P. knowlesi performed by a nested polymerase chain reaction (PCR) gel-based approach was confirmed by using a PCR-sequencing assay.
      PubDate: 2014-05-26T02:00:14.626499-05:
      DOI: 10.1111/jtm.12131
       
  • Chronic Schistosoma mekongi in a Traveler—A Case Report
           and Review of the Literature
    • Authors: Pauline Campa; Michel Develoux, Ghania Belkadi, Denis Magne, Charles Lame, Marie-Jeanne Carayon, Pierre-Marie Girard
      First page: 361
      Abstract: Travel-related schistosomiasis can be detected in patients without symptoms of acute or chronic infection. A case of Schistosoma mekongi acquired in an endemic area of Laos and discovered unexpectedly from colon biopsies taken 5 years after infection is presented here. A literature review of previous cases of S. mekongi infection specifically associated with travelers is then presented.
      PubDate: 2014-06-09T20:36:11.549501-05:
      DOI: 10.1111/jtm.12137
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2014